US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on October 29, 2026

Oct. 29, 2026

SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference

Indeterminate GlobeNewswire

Oct. 29, 2026

VYSTAR ENTERS STRATEGIC PARTNERSHIP INTO THE MOTION PICTURE INDUSTRY, WITH FILM AND TOKENIZATION CONTRACTS

Indeterminate GlobeNewswire

Oct. 29, 2026

Akebia Therapeutics to Report Third Quarter 2026 Financial Results and Discuss Recent Business Highlights

Indeterminate GlobeNewswire

Oct. 29, 2026

CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Oct. 29, 2026

Palvella Therapeutics to Host Third Quarter 2026 Financial Results and Corporate Update Conference Call on November 5, 2026

Indeterminate GlobeNewswire

Oct. 29, 2026

Cerenome Completes Enrollment in Phase 2 ReSPECT-GBM Trial of REYOBIQ™ in Recurrent Glioblastoma

Indeterminate GlobeNewswire

Oct. 29, 2026

Novastra Therapeutics to Present First-in-Human Data for OAP-101 in Checkpoint-Refractory Advanced Melanoma at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Indivior Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Indeterminate GlobeNewswire

Oct. 29, 2026

Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Oct. 29, 2026

Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth

Indeterminate GlobeNewswire

Oct. 29, 2026

Ligand Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 29, 2026

Iovance Reports Updated IOV-LUN-202 Results and Adds Precision TIL Strategy for Second-Line Metastatic Non-Small-Cell Lung Cancer (mNSCLC)

Indeterminate GlobeNewswire

Oct. 29, 2026

Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance

Indeterminate GlobeNewswire

Oct. 29, 2026

Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Oct. 29, 2026

Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences

Indeterminate GlobeNewswire

Oct. 29, 2026

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 29, 2026

Tilray Brands Announces Next Phase of Beverage Transformation

Indeterminate GlobeNewswire

Oct. 29, 2026

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026

Indeterminate GlobeNewswire

Oct. 29, 2026

Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026

Indeterminate GlobeNewswire